Eliem Therapeutics (ELYM) Competitors

FitLife Brands (NASDAQ:FTLF) and Eliem Therapeutics (NASDAQ:ELYM) are both small-cap medical companies, but which is the superior investment? We will contrast the two companies based on the strength of their dividends, community ranking, earnings, media sentiment, valuation, institutional ownership, profitability, risk and analyst recommendations.

Which has stronger earnings & valuation, FTLF or ELYM?

FitLife Brands has higher revenue and earnings than Eliem Therapeutics. Eliem Therapeutics is trading at a lower price-to-earnings ratio than FitLife Brands, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
FitLife Brands	$63.86M	2.04	$5.30M	$0.84	16.52
Eliem Therapeutics	N/A	N/A	-$35.12M	-$0.53	-2.58

Which has more volatility and risk, FTLF or ELYM?

FitLife Brands has a beta of 0.81, indicating that its stock price is 19% less volatile than the S&P 500. Comparatively, Eliem Therapeutics has a beta of -0.39, indicating that its stock price is 139% less volatile than the S&P 500.

Do analysts rate FTLF or ELYM?

FitLife Brands currently has a consensus price target of $20.50, suggesting a potential upside of 47.69%. Given FitLife Brands' stronger consensus rating and higher probable upside, equities research analysts plainly believe FitLife Brands is more favorable than Eliem Therapeutics.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
FitLife Brands	0 Sell rating(s)	0 Hold rating(s)	2 Buy rating(s)	1 Strong Buy rating(s)	3.33
Eliem Therapeutics	0 Sell rating(s)	0 Hold rating(s)	0 Buy rating(s)	0 Strong Buy rating(s)	0.00

Does the media favor FTLF or ELYM?

In the previous week, FitLife Brands had 2 more articles in the media than Eliem Therapeutics. MarketBeat recorded 2 mentions for FitLife Brands and 0 mentions for Eliem Therapeutics. FitLife Brands' average media sentiment score of 1.89 beat Eliem Therapeutics' score of 0.00 indicating that FitLife Brands is being referred to more favorably in the media.

Company	Overall Sentiment
FitLife Brands	Very Positive
Eliem Therapeutics	Neutral

Is FTLF or ELYM more profitable?

FitLife Brands has a net margin of 13.38% compared to Eliem Therapeutics' net margin of 0.00%. FitLife Brands' return on equity of 28.03% beat Eliem Therapeutics' return on equity.

Company	Net Margins	Return on Equity	Return on Assets
FitLife Brands	13.38%	28.03%	15.13%
Eliem Therapeutics	N/A	-47.03%	-45.97%

Does the MarketBeat Community prefer FTLF or ELYM?

Eliem Therapeutics received 6 more outperform votes than FitLife Brands when rated by MarketBeat users. Likewise, 56.25% of users gave Eliem Therapeutics an outperform vote while only 50.00% of users gave FitLife Brands an outperform vote.

Company	Underperform	Outperform
FitLife Brands	Outperform Votes 3 50.00%	Underperform Votes 3 50.00%
Eliem Therapeutics	Outperform Votes 9 56.25%	Underperform Votes 7 43.75%

Do institutionals & insiders believe in FTLF or ELYM?

2.3% of FitLife Brands shares are held by institutional investors. Comparatively, 69.8% of Eliem Therapeutics shares are held by institutional investors. 61.3% of FitLife Brands shares are held by company insiders. Comparatively, 4.7% of Eliem Therapeutics shares are held by company insiders. Strong institutional ownership is an indication that endowments, large money managers and hedge funds believe a company is poised for long-term growth.

Summary

FitLife Brands beats Eliem Therapeutics on 15 of the 18 factors compared between the two stocks.